Prognostic Analysis of Duodenal Gastrointestinal Stromal Tumors.
Liwen HongTianyu ZhangYun LinRong FanMaochen ZhangMengmeng ChengXiaolin ZhouJuntao SunPeijun SunQiangqiang WuLei WangZhengting WangJie ZhongPublished in: Gastroenterology research and practice (2018)
Prognosis for DGIST treated by R0 resection is favorable. High level of Ki-67 can be an independent risk factor of DGIST prognosis. Adjuvant imatinib therapy for patients with tumor recurrence could probably lead to prolonged survival.